Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Reveal The True Biology


Fluxion delivers advanced solutions that transform complex cell-based and cell-free assays. Leading labs across the globe rely on Fluxion's instruments, kits, and lab services to research novel biology, accelerate drug discovery, and tailor therapies based on patient-specific biomarkers.

Fluxion Biosciences

Application Focus

Core Technology

Automated Patch Clamp

IonFlux Mercury 16, HT, Ultra 128, ULTRA 256

IonFlux Mercury Systems

IonFlux

Core Technology

Cellular Analysis

BioFlux One, BioFlux 200, Bioflux 1000z, BioFlux DCIS

BioFlux Systems

BF100 Stage with Interface Attached-1

Core Technology

Liquid Biopsy

Spotlight 59 NGS Liquid Biopsy Panels, IsoFlux CTC System

IsoFlux CTC & Rare Cell System

Spotlight Liquid Biopsy NGS Panels

Plate_IsoFlux_Long

View more in our Resources Library

Resources Library

Latest News

UPCOMING EVENTS

Pharmacological Characterization of a Primary Nicotinic Receptor from the Neuromuscular Junction

Thursday May 26th. 11am Eastern, 12pm Central, 10am Pacific

Speakers: Andrew Cook, Senior Study Director, Eurofins...

Emerging Immunotherapies Are Revolutionizing Cancer and Immune Disease Treatment

 

Exciting New T Cell Therapies Present Unique Challenges in Drug Development.

Immunotherapeutics stimulate the...

The Many Modulators of Sleep

As we go through our lives, we spend a third of that time sleeping. Although this time does not amass to anything...

Liquid Biopsy Sensitivity and Accuracy: Are We There Yet?

A newly published paper coauthored by researchers at Fluxion and Hospices Civils de Lyon Cancer Institute tested the...